Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

2.77
Delayed Data
As of Mar 23
 -0.03 / -1.07%
Today’s Change
0.70
Today|||52-Week Range
2.90
+18.88%
Year-to-Date
No recent news for Antares Pharma Inc.

Today’s Trading

Previous close2.80
Today’s open2.81
Day’s range2.75 - 2.84
Volume836,920
Average volume (3 months)961,117
Market cap$430.0M
Dividend yield--
Data as of 03/23/2017

Growth & Valuation

Earnings growth (last year)-14.29%
Earnings growth (this year)--
Earnings growth (next 5 years)+54.50%
Revenue growth (last year)+14.38%
P/E ratioNM
Price/Sales6.92
Price/Book9.51

Competitors

 Today’s
change
Today’s
% change
CERSCerus Corp+0.06+1.48%
LMATLeMaitre Vascular In...+0.10+0.42%
XENTIntersect ENT Inc+0.65+4.14%
ELOSSyneron Medical Ltd0.000.00%
Data as of 03/23/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$52.2M
Annual profit (last year)-$24.3M
Net profit margin-46.61%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Robert F. Apple
Chief Financial Officer &
Senior Vice President
Fred M. Powell
Corporate headquarters
Ewing, New Jersey

Forecasts


Search for Jobs